Quarter Financials
Coherus BioSciences, Inc. (CHRS)
$2.3
+0.17 (+7.98%)
Income Statement
Balance Sheet
Cash Flow
|
Year
|
2023 Q3
|
2023 Q2
|
2023 Q1
|
2022 Q4
|
2022 Q3
|
2022 Q2
|
2022 Q1
|
2021 Q4
|
|---|
| Net Income | -40 | -43 | -75 | -66 | -93 | -56 | -111 | -46 |
|---|
| Dividend Paid | - | - | - | - | - | - | - | - |
|---|
| Retained Earnings | -1,500 | -1,460 | -1,417 | -1,342 | -1,283 | -1,196 | -1,146 | -1,050 |
|---|
|
Year
|
2023 Q3
|
2023 Q2
|
2023 Q1
|
2022 Q4
|
2022 Q3
|
2022 Q2
|
2022 Q1
|
2021 Q4
|
|---|
| Capital Expenditure | - | -0 | -0 | -0 | -0 | -1 | -1 | -0 |
|---|
| Net PPE | 6 | 7 | 8 | 9 | 10 | 10 | 8 | 8 |
|---|
|
Year
|
2023 Q3
|
2023 Q2
|
2023 Q1
|
2022 Q4
|
2022 Q3
|
2022 Q2
|
2022 Q1
|
2021 Q4
|
|---|
| New Purchases | -11 | - | - | - | -127 | - | - | - |
|---|
| Intangible and Goodwill | 1 | - | - | - | - | - | - | - |
|---|